HomeCompareMBRFF vs MRK

MBRFF vs MRK: Dividend Comparison 2026

MBRFF yields 5.10% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MBRFF wins by $6912.94M in total portfolio value
10 years
MBRFF
MBRFF
● Live price
5.10%
Share price
$69.25
Annual div
$3.53
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6913.00M
Annual income
$6,662,257,336.88
Full MBRFF calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — MBRFF vs MRK

📍 MBRFF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMBRFFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MBRFF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MBRFF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MBRFF
Annual income on $10K today (after 15% tax)
$433.86/yr
After 10yr DRIP, annual income (after tax)
$5,662,918,736.35/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, MBRFF beats the other by $5,662,910,139.63/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MBRFF + MRK for your $10,000?

MBRFF: 50%MRK: 50%
100% MRK50/50100% MBRFF
Portfolio after 10yr
$3456.53M
Annual income
$3,331,133,725.33/yr
Blended yield
96.37%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

MBRFF
No analyst data
Altman Z
3.2
Piotroski
5/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MBRFF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMBRFFMRK
Forward yield5.10%2.81%
Annual dividend / share$3.53$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$6913.00M$57.7K
Annual income after 10y$6,662,257,336.88$10,113.78
Total dividends collected$6895.44M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: MBRFF vs MRK ($10,000, DRIP)

YearMBRFF PortfolioMBRFF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,721$1,020.85$11,213$373.04+$508.00MBRFF
2$14,778$2,236.50$12,667$512.06+$2.1KMBRFF
3$21,083$5,270.66$14,439$708.14+$6.6KMBRFF
4$36,614$14,055.04$16,640$988.16+$20.0KMBRFF
5$84,801$45,623.86$19,432$1,394.07+$65.4KMBRFF
6$288,248$197,511.65$23,057$1,992.90+$265.2KMBRFF
7$1,563,319$1,254,893.31$27,889$2,894.79+$1.54MMBRFF
8$14,394,122$12,721,370.51$34,518$4,286.29+$14.36MMBRFF
9$234,337,970$218,936,260.05$43,912$6,494.35+$234.29MMBRFF
10$6,912,998,965$6,662,257,336.88$57,714$10,113.78+$6912.94MMBRFF

MBRFF vs MRK: Complete Analysis 2026

MBRFFStock

Mo-BRUK S.A. engages in the storage, disposal, and recycling of industrial, medical, and municipal waste in Poland, Germany, Italy, Slovenia, Denmark, and Lithuania. The company operates in four segments: Waste Management, Construction Services, Petrol Stations, and Secondary Products. It provides incineration, and solidification and stabilization of hazardous, organic, and inorganic waste. The company also offers construction services, including construction of concrete pavement, roads, and squares. In addition, it owns and operates fuel stations that provide sale of liquid fuels, LPG, and diagnostic services; produces alternative fuel from municipal and industrial waste; and provides laboratory services. The company was founded in 1985 and is headquartered in Korzenna, Poland.

Full MBRFF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this MBRFF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MBRFF vs SCHDMBRFF vs JEPIMBRFF vs OMBRFF vs KOMBRFF vs MAINMBRFF vs JNJMBRFF vs ABBVMBRFF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.